TrialPediatric dermatology2020

Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.

Adelaide A Hebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.